Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements Of Operations And Comprehensive Loss (Unaudited)

v3.22.2.2
Consolidated Statements Of Operations And Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Net revenue $ 12,010 $ 9,531 $ 34,411 $ 26,780
Cost of revenue 9,565 4,689 22,096 15,157
Gross profit 2,445 4,842 12,315 11,623
Operating expenses:        
Sales and marketing 5,008 3,451 15,224 10,315
General and administrative 3,109 2,479 8,825 8,613
Engineering and development 1,979 1,540 5,177 4,506
Loss on patent litigation settlement 0 29   190
Total operating expenses 10,096 7,499 29,226 23,624
Loss from operations (7,651) (2,657) (16,911) (12,001)
Loss on foreign currency transactions (329) (36) (552) (172)
Interest expense, net (424) (569) (1,287) (1,727)
Gain on debt forgiveness 0 0 0 3,014
Non-operating income (loss), net (753) (605) (1,839) 1,115
Loss before income tax (provision) benefit (8,404) (3,262) (18,750) (10,886)
Income tax (provision) benefit 17 (14) (23) 7
Net income (loss) (8,387) (3,276) (18,773) (10,879)
Other comprehensive loss items:        
Foreign currency translation adjustments (152) (90) (415) (173)
Comprehensive income (loss) (8,539) (3,366) (19,188) (11,052)
Net income (loss) (8,387) (3,276) (18,773) (10,879)
Deemed dividend on convertible preferred stock 0 (9) (217) (546)
Net loss attributable to common stockholders $ (8,387) $ (3,285) $ (18,990) $ (11,425)
Net loss per share attributable to common stockholders:        
Basic and Diluted - Note 1 $ (1.10) $ (0.54) $ (2.85) $ (1.96)
Basic and Diluted - Note 1 $ (1.10) $ (0.54) $ (2.85) $ (1.96)
Shares used in the calculation of net loss per share:        
Basic and Diluted - Note 1 7,615 6,078 6,661 5,832
Basic and Diluted - Note 1 7,615 6,078 6,661 5,832